Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Breast cancer is the second most common type of cancer in women after skin cancer. It is caused by uncontrollable growth in breast cells which then accumulate, resulting in the formation of a lump or mass. Breast cancer can be caused by mutations in genes. Some of […]
Avani Dave, Jai Hind College Breast cancer gene BRCA1 has marked its presence as a protein mostly known for being an active contributor in the hereditary associated breast cancer. Apart from being the villain, BRCA1 also plays an indispensable role in the cellular machinery that works towards repairing the double-strand DNA breakage. Recently, researchers from […]
Saptaparna Dasgupta, Bennett University The intermediate and transitory reaction of breast-tumour stiffness to pathological rigidity has been carefully investigated in their native microwave environment. However, it remains unclear how the main phenotypes of stiffness caused by the cancer cell are stained in vivo over a while. Certain mechanisms are associated based on how fibrotic-like matrix […]
Sapataparna Dasgupta, Bennett University Little study has been done on nanoparticles as biocompatible drug delivery carriers. Cancer, being the most lethal disease and the greatest cause of death worldwide, emerges as the most researched disease in the current scenario. Amongst cancer, breast cancer stands to be the leading cause of death for women all over […]
Akash Singh, Banaras Hindu University The mammary gland is an ectodermal exocrine gland whose major job is to generate milk for offspring’s sustenance. Mammary gland morphogenesis begins during the embryonic phase in humans and most mammals, but the most essential component of mammary growth and remodelling happens after birth, during puberty, pregnancy, breastfeeding, and involution. […]
Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]
Thota Kanishka Rao, Amity University Kolkata Researchers have commenced on re-established investigations concerning androgen treatment – a precursory breast cancer treatment, as recent findings in mice have shown that it might help to restrict tumor development. In 2020, approximately 2 million people in the United States were diagnosed with this cancer. Around 15% of those […]
Sayak Banerjee, Amity University Kolkata According to the scientists at Baylor College of Medicine, antiviral immune pathways in triple-negative breast cancers (TNBC) can be activated by therapeutics targeting RNA splicing along with the stimulation of tumour cell death. Around 10-20% of breast cancers are triple-negative, which signifies that they are negative not only for estrogen […]
Parnad Basu, Amity University Kolkata Breast cancer is the second most common cancer in the United States, which happens to women but is also seen in men in some rare cases. Now, triple-negative breast cancer (TNBC) is a specific type of breast cancer where the cancer cells show negative results for estrogen receptor, progesterone receptor, […]
Anish Pyne, Indian Institute of Technology Kharagpur Although we usually tend to fear the painful sting of a Honeybee since our early childhood days, science offers a different perspective for it. Studies suggest that honeybee venom can be one of the most crucial weapons for mankind. Recently, an in vitro study conducted in Harry Perkins […]
